top of page

Lazcluze Film-coated Tablets 240mg

Product details

Registration number: SIN17348P

Classification: Prescription Only

Active ingredients: Lazertinib Mesylate Monohydrate eqv Lazertinib

Strength: 240 mg

Dosage form: TABLET, FILM COATED

Route: ORAL

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

ATC code: L01EB09

HSA approval date: 2 October 2025

Manufacturer(s): Janssen Cilag SpA

Manufacturing country/countries: ITALY

What are the HSA registration number and classification for Lazcluze Film-coated Tablets 240mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17348P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Lazcluze Film-coated Tablets 240mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Lazertinib Mesylate Monohydrate eqv Lazertinib

Strength: 240 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Lazcluze Film-coated Tablets 240mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET, FILM COATED

Route: ORAL

Source for this answer

Who is the recorded registrant for Lazcluze Film-coated Tablets 240mg?

According to the HSA dataset updated 7 August 2026:

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for Lazcluze Film-coated Tablets 240mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Janssen Cilag SpA

Manufacturing country/countries: ITALY

Source for this answer

Where can I look up Lazcluze Film-coated Tablets 240mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17348P or the exact product name Lazcluze Film-coated Tablets 240mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Lazcluze Film-coated Tablets 240mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Lazcluze Film-coated Tablets 240mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17348P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page